When is it appropriate to stop antiplatelet therapy in a patient with a drug-eluting stent prior to noncardiac surgery?

Cleveland Clinic Journal of Medicine

Volumn 73, Issue ELECTRONIC SUPPL., 2006, Pages 7-9

  Rajamanickam, Anitha ^a   Singh, Vaishali ^a   Aneja, Ashish ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ARTICLE; CARDIOVASCULAR DISEASE; HUMAN; PERIOPERATIVE PERIOD; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; RISK; STENT; SURGERY;

CARDIOVASCULAR DISEASES; HUMANS; INTRAOPERATIVE COMPLICATIONS; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; RISK; STENTS; SURGICAL PROCEDURES, OPERATIVE;

EID: 34547399896     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.73.Electronic_Suppl_1.S7     Document Type: Note

References (13)

1. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2006; 47:216-235.
2. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293:2126-2130.
3. Moreno R, Fernandez C, Hernandez R, et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005; 45:954-959.
4. Pfisterer ME, Kaiser CA, Bader F, et al. Late clinical events related to late stent thrombosis after stopping clopidogrel: prospective randomized comparison between drug-eluting versus bare-metal stenting. Program and abstracts of the American College of Cardiology 55th Annual Scientific Session; March 11-14, 2006; Atlanta, GA. Abstract 422-11.
5. Ong AT, McFadden EP, Regar E, et al. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005; 45:2088-2092.
6. Kaluza GL, Joseph J, Lee JR, et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000; 35:1288-1294.
7. Wilson SH, Fasseas P, Orford JL, et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003; 42:234-240.
8. Sharma AK, Ajani AA, Hamwi SH, et al. Major noncardiac surgery following coronary stenting: when is it safe to operate? Catheter Cardiovasc Interv 2004; 63:141-145.
9. Vicenzi MN, Meislitzer T, Heitzinger B, Halaj M, Fleisher LA, Metzler H. Coronary artery stenting and non-cardiac surgery-aprospective outcome study. Br J Anaesth 2006; 96:686-693.
10. Bakhru M, Saber W, Brotman D, et al. Is discontinuation of antiplatelet therapy after 6 months safe in patients with drug-eluting stents undergoing noncardiac surgery? Oral abstract presented at 2nd Annual Perioperative Medicine Summit; Sept. 18-19, 2006; Cleveland, OH. Cleve Clin J Med 2006; 73(E-Suppl 1):S23.
11. Kuchulakanti PK, Chu WW, Torguson R, et al. Correlates and longterm outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 2006; 113:1108-1113.
12. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004; 351:2795-2804.
13. Auerbach A, Goldman L. Assessing and reducing the cardiac risk of noncardiac surgery. Circulation 2006; 113:1361-1376.